Volume 9, Issue 3 (2-2024)
SJNMP 2024, 9(3): 225-236 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ebrahimi M, Karamelahi Z, Kamkar M Z. Investigation of the frequency of psychiatric symptoms in irritable bowel syndrome patients one year after diagnosis Compared with the control group by self-assessment. SJNMP 2024; 9 (3) :225-236
URL: http://sjnmp.muk.ac.ir/article-1-580-en.html
URL: http://sjnmp.muk.ac.ir/article-1-580-en.html
1- Golestan University of Medical Sciences, Gorgan, Iran.
2- Clinical Research Development Unit 5azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran& Department of Midwifery, Ilam University of Medical Sciences, Ilam, Iran
3- Department of Psychiatry, Golestan Research Center of Psychiatry, Golestan University of Medical Sciences, Gorgan, Iran ,kamkar72@yahoo.com
2- Clinical Research Development Unit 5azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran& Department of Midwifery, Ilam University of Medical Sciences, Ilam, Iran
3- Department of Psychiatry, Golestan Research Center of Psychiatry, Golestan University of Medical Sciences, Gorgan, Iran ,
Abstract: (708 Views)
Background & Aim: Irritable bowel syndrome (IBS) is a functional disorder of the gastrointestinal tract that affects 5-30% of the world's population and is characterized by abdominal pain and changes in bowel habits. It has been shown that mood; anxiety and physical disorders are associated with different degrees of psychological distress in patients with IBS. The purpose of the present study is to compare the frequency of psychiatric symptoms of irritable bowel syndrome patients one year after diagnosis with the control group using self-assessment method. Materials & methods: In this descriptive-cross-sectional study, the number of 48 patients with irritable bowel syndrome (according to the Rome IV criteria) and 48 non-sufferers among those who referred to the gastroenterology clinic of Shahid Sayad Shirazi Hospital in Gorgan, with the available sampling method Selection and study were entered. Informed consent was obtained from the participants. Data were collected using checklist and SCL-90-R questionnaire. Then, using SPSS version 16 software and chi-square and Mann-Whitney tests, they were analyzed statistically. Results: The two groups of case and control were similar in terms of demographic variables, including age, gender, education, marital status, and place of residence (p<0.05). There was no difference between the two groups in terms of the total score and the score of the subscales of SCL-90-R (p<0.05). None of the demographic variables and psychiatric symptoms were identified as risk factors for IBS (p<0.05). Conclusion: Based on the results of this study, patients with irritable bowel syndrome are similar to non-affected people in terms of psychiatric symptoms. Also, demographic variables and psychiatric symptoms are risk factors for they did not suffer from irritable bowel syndrome.
Type of Study: Research |
Subject:
General
Received: 2023/11/28 | Revised: 2024/03/17 | Accepted: 2024/02/29 | Published: 2024/02/29 | ePublished: 2024/02/29
Received: 2023/11/28 | Revised: 2024/03/17 | Accepted: 2024/02/29 | Published: 2024/02/29 | ePublished: 2024/02/29
References
1. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949-58. [DOI:10.1001/jama.2015.0954]
2. Sibelli A, Chalder T, Everitt H, Chilcot J, MossMorris R. Positive and negative affect mediate the bidirectional relationship between emotional processing and symptom severity and impact in irritable bowel syndrome. Journal of psychosomatic research. 2018;10(5):1-3 [DOI:10.1016/j.jpsychores.2017.11.016]
3. Mearin F, Ciriza C, Mínguez M, Rey E, Mascort JJ, Peña E, Cañones P, Júdez J. Clinical Practice Guideline: Irritable bowel syndrome with constipation and functional constipation in the adult. Rev Esp Enferm Dig. 2016;108(6):332-63. [DOI:10.17235/reed.2016.4389/2016]
4. Camilleri M. Diagnosis and Treatment of Irritable Bowel Syndrome: A Review. JAMA. 2021;325(9):865-877. [DOI:10.1001/jama.2020.22532]
5. Grad S, Dumitrascu DL. Irritable bowel syndrome subtypes: new names for old medical conditions. Digestive diseases. 2020;38(2):122-27 [DOI:10.1159/000505287]
6. Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. The lancet Gastroenterology & hepatology. 2020;5(10):908-17. [DOI:10.1016/S2468-1253(20)30217-X]
7. Sperber AD, Dumitrascu D, Fukudo S, Gerson C, Ghoshal UC, Gwee KA, Hungin APS, Kang JY, Minhu C, Schmulson M, Bolotin A, Friger M, Freud T, Whitehead W. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut. 2017;66(6):1075-1082. [DOI:10.1136/gutjnl-2015-311240]
8. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712-721. [DOI:10.1016/j.cgh.2012.02.029]
9. Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol. 2012;107(7):991-1000. [DOI:10.1038/ajg.2012.131]
10. Park JH, Kang SH, Kim JS, Moon HS, Sung JK, Jeong HY. Contribution of sex and gender roles to the incidence of post-infectious irritable bowel syndrome in a prospective study. Scientific Reports. 2023;13(1):19467. [DOI:10.1038/s41598-023-45300-2]
11. Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17(8):473-486. [DOI:10.1038/s41575-020-0286-8]
12. Roshandel D, Rezailashkajani M, Shafaee S, Zali MR. A cost analysis of functional bowel disorders in Iran. Int J Colorectal Dis. 2007;22(7):791-9. [DOI:10.1007/s00384-006-0226-2]
13. Zamani M, Alizadeh-Tabari S, Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2019;50(2):132-143. [DOI:10.1111/apt.15325]
14. Van Oudenhove L, Crowell MD, Drossman DA, Halpert AD, Keefer L, Lackner JM, Murphy TB, Naliboff BD, Levy RL. Biopsychosocial Aspects of Functional Gastrointestinal Disorders. Gastroenterology. 2016:S0016-5085(16)00218-3.
15. Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ. The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012;61(9):1284-90. [DOI:10.1136/gutjnl-2011-300474]
16. Quigley EMM. The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS). J Clin Med. 2018;7(1):6. [DOI:10.3390/jcm7010006]
17. Farbod F, Farzaneh N, Bijan MD, Mehdi G, Nosratollah N. Psychological features in patients with and without irritable bowel syndrome: A case-control study using Symptom Checklist-90-Revised. Indian J Psychiatry. 2015;57(1):68-72. [DOI:10.4103/0019-5545.148526]
18. Tabrizizadeh M, Yasini Ardakani SM, Rostamzade P, Zare M. The Mental Health Status of Students of Medicine and Dentistry A Study in Shahid Sadoughi University of Medical Sciences Yazd Iran. Strides in Development of Medical Education. 2013;9(2):153-61.
19. Akhavan Abiri F, Shairi MR. Validity and Reliability of Symptom Checklist-90-Revised (SCL-90-R) and Brief Symptom Inventory-53 (BSI-53). Clinical Psychology and Personality. 2020;17(2):169-95. [Persian]
20. Derogatis LR. Symptom Checklist-90-Revised. In: Rush A, First MB, Blacker D. Handbook of psychiatric measures. 2nd ed. Washington, DC: American psychiatric association; 2008. p.81-84.
21. Bagheri L. Comparison of family solidarity, mental health and religious orientation in runaway and normal girls in Tehran. Master's thesis 2013. [Persian]
22. Torun F, Koç G, Ocak Serın S, Dılek Torun S. Psychiatric symptoms and relationship of disease with stress and traumatic experiences in patients with irritable bowel syndrome. Riv Psichiatr. 2020;55(5):292-296.
23. Farbod F, Farzaneh N, Bijan MD, Mehdi G, Nosratollah N. Psychological features in patients with and without irritable bowel syndrome: A case-control study using Symptom Checklist-90-Revised. Indian J Psychiatry. 2015;57(1):68-72. [DOI:10.4103/0019-5545.148526]
24. Kang JY. Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther. 2005;21(6):663-76. [DOI:10.1111/j.1365-2036.2005.02396.x]
25. Piacentino D, Cesarini M, Badiali D, Pallotta N, Biondi M, Corazziari ES. The central role of psychopathology and its association with disease severity in inflammatory bowel disease and irritable bowel syndrome. Riv Psichiatr. 2019;54(2):75-83.
26. North CS, Hong BA, Alpers DH. Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment. World J Gastroenterol. 2007;13(14):2020-7. [DOI:10.3748/wjg.v13.i14.2020]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
